Status:
RECRUITING
The Effect Of Botox In Patients With Gummy Smile With And Without Zinc And Phytase Supplementation.
Lead Sponsor:
Cairo University
Conditions:
Excessive Gingival Display
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Participants with esthetic concern of excessive gingival display who meets the inclusion criteria, will be carried out including history taking, clinical examination and initial therapy. The initial ...
Detailed Description
Initial examination: Participants with esthetic concern of excessive gingival display who meets the inclusion criteria, will be carried out including history taking, clinical examination and initial ...
Eligibility Criteria
Inclusion
- Patients with excessive gingival display \>3mm and with normal clinical crown dimensions.
- Adults \>18 years.
- Non-smokers.
- Systemically healthy.
- Hypermobile lip and mild VME.
Exclusion
- Severe VME.
- Pregnant or lactating females.
- Patients with inflamed gingiva or gingival enlargement.
- Inflammation or infection at the site of injection.
- Patients with known allergy to any of the components of BTX-A or BTX-B (i.e. BTX, human albumin, saline, lactose and sodium succinate).
- Patients using anticholinesterase or other agents interfering with neuromuscular transmission.
- Psychologically unstable or who have questionable motives and unrealistic expectations.
- Dependent on intact facial movements and expressions for their livelihood (e.g. actors, singers, musicians and other media personalities).
- Afflicted with a neuromuscular disorder (e.g. myasthenia gravis, Eaton- Lambert syndrome).
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06577285
Start Date
June 1 2024
End Date
June 1 2025
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry Cairo University
Cairo, Egypt